tirzepatide patent status As Novo's expires, GLP-1 generics go global BPI challenges Eli Lilly's patent

Using techniques to relax, getting enough rest, and staying active can help tirzepatide work better

Researchers say larger, longer studies in broader populations are also needed to determine whether the changes captured by epigenetic clocks translate into more years of healthy life

Clinical trials report headache incidence between 5% and 10% of tirzepatide users, making it a less common side effect than nausea or constipation

We provide a telehealth-first platform that connects you with licensed providers who understand the nuances of GLP-1 treatments

While most vision changes are temporary and benign, sustained symptoms could indicate more serious complications like worsening diabetic retinopathy or, rarely, developing NAION

Individual reactions vary, and factors like dosage and diet can influence tolerability